Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-03-19

Clinical Trial Update: Study Evaluating the Effect of Jublia on Dermatophytomas [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effect of Jublia on dermatophytomas in onychomycosis and dermatophytosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JUBLIA (efinaconazole)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Onychomycosis, Dermatophytosis | Phase 4 | Status: COMPLETED | Results posted: 2019-03-19